
|Articles|April 15, 2016
Do Opioid Prescribing Guidelines Use Pseudoscience?
Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP, discusses how opioid prescribing guidelines use pseudoscience.
Advertisement
Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP, discusses how opioid prescribing guidelines use pseudoscience.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
2
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
3
FDA Approves T-DXd With Pertuzumab for First-Line Treatment of Advanced HER2+Breast Cancer
4
FDA Approval Signals Broader Recognition of Sexual Health in Aging Women
5

















































































































































































































